Vapotherm takes pride in pioneering the development of the initial heated and humidified high-flow nasal cannula system designed to address undifferentiated respiratory distress across the age spectrum, from neonates to adults. Our devices have been utilized in the treatment of over 4 million patients, contributing to a widespread global presence with an installed base exceeding 37,000 capital units. We recognize that innovation is only possible with education - stop by our booth to learn more about our devices in the ED to treat the severe hypercapnic patients!